The Long Run with Luke Timmerman

Timmerman Report
undefined
Jun 27, 2023 • 1h

Ep138: Jodie Morrison on Becoming a Biotech CEO

Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.
undefined
Jun 14, 2023 • 57min

Ep137: Aaron Ring on Immunotherapy for Cancer & More

Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.
undefined
May 30, 2023 • 53min

Ep136: Deborah Palestrant on Building Biotech Startups

Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.
undefined
11 snips
May 8, 2023 • 1h 4min

Ep135: John Maraganore on Developing a New Class of Medicines

John Maraganore, founding CEO of Alnylam Pharmaceuticals who led development of RNA interference therapeutics. He recounts the long road to creating a new drug class. Topics include RNAi delivery challenges, strategic use of LNPs and GalNAc conjugates, target selection and rare-disease commercial strategy, clinical setbacks and recoveries, partnerships that validated the approach, and how computation and AI are accelerating discovery.
undefined
Apr 24, 2023 • 1h 16min

Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies

Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.
undefined
Apr 12, 2023 • 1h 11min

Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies

Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.
undefined
Mar 28, 2023 • 1h 6min

Ep132: Eric Dobmeier on Treating Kidney Disease

Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.
undefined
Mar 14, 2023 • 1h 6min

Ep131: Ryan Watts on Neuroscience Drug R&D

Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.
undefined
Feb 28, 2023 • 1h 9min

Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave

David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.
undefined
4 snips
Feb 14, 2023 • 1h 12min

Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies

Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app